PapersPMID:39964702
Effect of lutein supplementation on blood lipids and advanced glycation end products in adults with central obesity: a double-blind randomized controlled trial.
- 01 · findings
- 2
- 02 · compound
- 1
- 03 · endpoints
- 2
- 04 · null
- 0
What it reported
How to read these marksWhat moved
2 findings
lutein — decreases LDL cholesterol
Evidence strength: very limited.Finding“Both intention-to-treat analysis and the per-protocol analysis showed significant reductions in plasma total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, and malonaldehyde levels in the lutein supplementation group compared with the placebo group.”
Quoted verbatim from Effect of lutein supplementation on blood lipids and advanced glycation end products in adults with central obesity: a double-blind randomized controlled trial.. - Study
- RCT
- Duration
- 7 months
- Dose
- 10 mg/day lutein
- Population
- adults with central obesity
Effect of lutein supplementation on blood lipids and advanced glycation end products in adults with central obesity: a double-blind randomized controlled trial.2025PMID:3996470210.1039/d4fo05578kPermalink
lutein — decreases total cholesterol (TC)
Evidence strength: very limited.Findingreplicated ×1“Both intention-to-treat analysis and the per-protocol analysis showed significant reductions in plasma total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, and malonaldehyde levels in the lutein supplementation group compared with the placebo group.”
Quoted verbatim from Effect of lutein supplementation on blood lipids and advanced glycation end products in adults with central obesity: a double-blind randomized controlled trial.. - Study
- RCT
- Duration
- 7 months
- Dose
- 10 mg/day lutein
- Population
- adults with central obesity
Effect of lutein supplementation on blood lipids and advanced glycation end products in adults with central obesity: a double-blind randomized controlled trial.2025PMID:3996470210.1039/d4fo05578kPermalink
Study record
Read under: lutein
- Design
- randomised controlled trial
- Species
- human
- Population
- adults with central obesity
- Participants
- not recorded
- Comparator
- not stated in the paper
- Duration
- 224 days
- Endpoints
- 7
- Record
- extracted
- Readings recorded
- 2